INTRA-CELLULAR THERAPIES INC. news, videos and press releases
For more news please use our advanced search feature.
INTRA-CELLULAR THERAPIES INC. - More news...
INTRA-CELLULAR THERAPIES INC. - More news...
- Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
- Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
- INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
- ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders
- INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
- Shareholder Alert: Ademi LLP investigates whether Intra-Cellular Therapies, Inc. is obtaining a Fair Price for its Public Shareholders
- $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Intra-Cellular Therapies, Inc. - ITCI
- ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-Cellular Therapies, Inc. Is Fair to Shareholders
- Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Intra-Cellular Therapies, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
- INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Intra-Cellular Therapies, Inc. with Losses to Contact the Firm
- INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Intra-Cellular Therapies, Inc. with Losses to Contact the Firm
- Key Binding Characteristics of Dusquetide to Important Intracellular Protein Identified
- Thinking about buying stock in Intra-Cellular Therapies, Selecta Biosciences, Coherus Biosciences, ImmunityBio, or SeaChange International?
- OliX Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Improved Intracellular Delivery Platform Technology for RNAi Therapeutics
- Complix Signs Global Drug Discovery and Development Agreement with I-Mab to Develop Cell Penetrating Alphabodies against Two Intracellular Immuno-oncology Targets
-
Intra-Cellular Therapies, Inc. - ITCI Stock Chart Technical Analysis for 09-09-2020
- Thinking about buying stock in Intra-Cellular Therapies, AMC Entertainment, Vaxart Inc, Norwegian Cruise Line, or Southwest Airlines?
-
Intra-Cellular Therapies, Inc. - ITCI Stock Chart Technical Analysis for 12-24-2019
-
Intra-Cellular Therapies, Inc. - ITCI Stock Chart Technical Analysis for 12-23-2019
-
Intra-Cellular Therapies, Inc. - ITCI Stock Chart Technical Analysis for 07-23-2019
-
Intra-Cellular Therapies, Inc. - ITCI Stock Chart Technical Analysis for 07-08-2019
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intra-Cellular Therapies, Inc. - ITCI
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intra-Cellular Therapies, Inc. - ITCI
- Investor Expectations to Drive Momentum within Tribune Media, Intra-Cellular Therapies, Icahn Enterprises, NVE, PetMed Express, and United Fire Group — Discovering Underlying Factors of Influence
- Recent Analysis Shows Eagle Bulk Shipping, QCR, Intra-Cellular Therapies, PGT, Northeast, and Ferrellgas Partners Market Influences — Renewed Outlook, Key Drivers of Growth
- Intra-Cellular Therapies, Inc. to Host Earnings Call
- EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Intra-Cellular Therapies, Inc. - ITCI
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intra-Cellular Therapies, Inc. of Class Action Lawsuit and Upcoming Deadline - ITCI
- LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Intra-Cellular Therapies, Inc. To Contact The Firm